āagman

Not investment advice. Data and computed figures, for information only.

Krishna Institute of Medical Sciences Ltd

NSE: KIMS
₹688.65
−₹4.30 (−0.62%)
NSE · 15 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹29,631 Cr
CMP
₹688.65
52-wk High / Low
₹858 / 576
P/E
142.0
P/B
12.6
Book Value
₹56.2
Div Yield
0.00%
ROCE
10.0%
ROE
11.3%
Face Value
₹2
D/E
1.89

Price−1.7% over 1Y

āagman read

Computed by āagman
Derived from 11 years and 14 quarters of filings. Not reported by the company.
As of 15 Oct 2026
How we compute these
Piotroski F-Score
4
/ 9
4 of 9 F-score tests passed
Graham Number
₹87
√(22.5 × EPS × book value per share)
ROIC
5.9%
vs 11.2% sector median
Cash flow to profit
2.11
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−323
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
11.3%
ROE × earnings retention ratio
ROE stability
4.7
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom −1.62FII +0.18DII +1.92
Latest quarter vs the previous one
Cash-accrual divergence
−4.0%
of assets
Low = accruals track cash flow
Strengths
Watch-outs
−Latest ROCE of 10% trails the sector median of 17%
−Borrowings are up 1561.3% since FY2016 (256 to 4253)
−Price trades below its 200-day moving average (1.0x)
−Promoter holding fell by 6.4pp over the last year

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales6066526066346887777727978729619981,0751,180
Expenses449475459475509559585599679757799868956
Operating Profit157177147159179218187198193204199206223
OPM %25.9%27.1%24.3%25.1%26.0%28.1%24.2%24.8%22.1%21.2%19.9%19.2%18.9%
Other Income3334551815745117
Interest991216182026273345576883
Depreciation323335463941455353667985101
Profit before tax11913910210012716213513411497695557
Net Profit87101777295121921068572523337
EPS (₹)2.022.301.801.642.162.682.222.541.961.671.331.060.99

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 11 years + TTM
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5125676649181,1231,3301,6512,1982,4983,0353,9054,212
Expenses4034505938338729531,1261,5871,8502,2423,0903,380
Operating Profit1091187185251377524611648793815833
OPM %21.3%20.8%10.7%9.3%22.4%28.3%31.7%27.8%25.9%26.1%20.9%19.8%
Other Income5337659274113431728
Interest373288494437223755100215253
Depreciation36354056717073129147177283331
Profit before tax4153−20−15141279457485460558334277
Net Profit2833−46−49115205344366336415242194
EPS (₹)0.760.91−1.32−1.283.205.198.328.417.759.616.035.05

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital7072507474788080808080—
Reserves193255−2094665247861,3071,5901,7482,0582,167—
Borrowings2562807533363693162576781,3552,5624,253—
Other Liabilities1461673592372282532605536369901,190—
Total Liabilities6657749541,1141,1941,4331,9042,9013,8205,6897,691—
Fixed Assets5155187558639169311,0051,7662,4343,3485,710—
CWIP2640029214776001,214606—
Investments111400003326815799103—
Other Assets1371771992502764935465906291,0281,271—
Total Assets6657749541,1141,1941,4331,9042,9013,8205,6897,691—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity9582106134202356324432521582511
Cash from Investing Activity−41−100−64−110−125−354−412−416−753−1,116−1,452
Cash from Financing Activity−6524−39−27−44106120217543940
Net Cash Flow−1153−33212−2636−159−1

Ratios

As of 31 Mar 2026
11 periods
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %—15.011.05.020.029.034.024.017.015.010.0
ROE %——————————11.3
EPS (₹)0.760.91−1.32−1.283.205.198.328.417.759.616.03
Book Value (₹)——————————56.2
Face Value (₹)——————————2
P/E——————————142.0
Div Yield %——————————0.00
NPM %5.45.8−6.6−5.310.215.320.516.313.413.56.2
OPM %21.021.011.09.022.028.032.028.026.026.021.0
D/E0.970.86—0.620.620.370.190.410.741.201.89
P/B——————————12.6

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+23.0%
5 years+24.0%
3 years+21.0%
TTM+31.0%
Compounded profit growth
10 years+25.0%
5 years+4.0%
3 years−9.0%
TTM−43.0%
Stock price CAGR
5 years+25.0%
3 years+23.0%
Last year+1.0%
Return on equity
10 years18.0%
5 years18.0%
3 years15.0%
Last year11.0%

Shareholding pattern

As of 31 Dec 2024
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters38.84%38.84%38.85%38.82%38.82%34.11%32.49%
FIIs8.91%8.91%19.41%16.73%15.44%14.57%14.75%
DIIs21.02%21.02%29.76%33.13%31.95%32.50%34.42%
Government———————
Public31.23%31.23%11.99%11.32%13.78%18.82%18.32%
No. of shareholders73,66473,66460,98069,0921,01,89593,33394,730
Change since Jun 2023 (pp)
Promoters −6.35FIIs +5.84DIIs +13.40Public −12.91

Documents

As of 11 Oct 2026
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018General Update On Query Received From BSEGeneral Update To Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015.Announcement under Regulation 30 (LODR)-AcquisitionAnnouncement under Regulation 30 (LODR)-Acquisition
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingMay 2026TranscriptMay 2026PPTMay 2026RecordingFeb 2026TranscriptFeb 2026PPTFeb 2026RecordingNov 2025TranscriptNov 2025PPTNov 2025RecordingNov 2025PPT

Corporate actions

As of 13 Sep 2024
13 Sep 2024SPLITFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share10 : 2
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman